1 Study Coverage
    1.1 Rabies Immunoglobulins Product Introduction
    1.2 Market by Type
        1.2.1 Global Rabies Immunoglobulins Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 ERIG
        1.2.3 HRIG
    1.3 Market by Application
        1.3.1 Global Rabies Immunoglobulins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Category II Exposure
        1.3.3 Category III Exposure
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Rabies Immunoglobulins Sales Estimates and Forecasts 2017-2028
    2.2 Global Rabies Immunoglobulins Revenue Estimates and Forecasts 2017-2028
    2.3 Global Rabies Immunoglobulins Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Rabies Immunoglobulins Sales by Region
        2.4.1 Global Rabies Immunoglobulins Sales by Region (2017-2022)
        2.4.2 Global Sales Rabies Immunoglobulins by Region (2023-2028)
    2.5 Global Rabies Immunoglobulins Revenue by Region
        2.5.1 Global Rabies Immunoglobulins Revenue by Region (2017-2022)
        2.5.2 Global Rabies Immunoglobulins Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Rabies Immunoglobulins Sales by Manufacturers
        3.1.1 Global Top Rabies Immunoglobulins Manufacturers by Sales (2017-2022)
        3.1.2 Global Rabies Immunoglobulins Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rabies Immunoglobulins in 2021
    3.2 Global Rabies Immunoglobulins Revenue by Manufacturers
        3.2.1 Global Rabies Immunoglobulins Revenue by Manufacturers (2017-2022)
        3.2.2 Global Rabies Immunoglobulins Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Rabies Immunoglobulins Revenue in 2021
    3.3 Global Rabies Immunoglobulins Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Rabies Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Rabies Immunoglobulins Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Rabies Immunoglobulins Sales by Type
        4.1.1 Global Rabies Immunoglobulins Historical Sales by Type (2017-2022)
        4.1.2 Global Rabies Immunoglobulins Forecasted Sales by Type (2023-2028)
        4.1.3 Global Rabies Immunoglobulins Sales Market Share by Type (2017-2028)
    4.2 Global Rabies Immunoglobulins Revenue by Type
        4.2.1 Global Rabies Immunoglobulins Historical Revenue by Type (2017-2022)
        4.2.2 Global Rabies Immunoglobulins Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Rabies Immunoglobulins Revenue Market Share by Type (2017-2028)
    4.3 Global Rabies Immunoglobulins Price by Type
        4.3.1 Global Rabies Immunoglobulins Price by Type (2017-2022)
        4.3.2 Global Rabies Immunoglobulins Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Rabies Immunoglobulins Sales by Application
        5.1.1 Global Rabies Immunoglobulins Historical Sales by Application (2017-2022)
        5.1.2 Global Rabies Immunoglobulins Forecasted Sales by Application (2023-2028)
        5.1.3 Global Rabies Immunoglobulins Sales Market Share by Application (2017-2028)
    5.2 Global Rabies Immunoglobulins Revenue by Application
        5.2.1 Global Rabies Immunoglobulins Historical Revenue by Application (2017-2022)
        5.2.2 Global Rabies Immunoglobulins Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Rabies Immunoglobulins Revenue Market Share by Application (2017-2028)
    5.3 Global Rabies Immunoglobulins Price by Application
        5.3.1 Global Rabies Immunoglobulins Price by Application (2017-2022)
        5.3.2 Global Rabies Immunoglobulins Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Rabies Immunoglobulins Market Size by Type
        6.1.1 North America Rabies Immunoglobulins Sales by Type (2017-2028)
        6.1.2 North America Rabies Immunoglobulins Revenue by Type (2017-2028)
    6.2 North America Rabies Immunoglobulins Market Size by Application
        6.2.1 North America Rabies Immunoglobulins Sales by Application (2017-2028)
        6.2.2 North America Rabies Immunoglobulins Revenue by Application (2017-2028)
    6.3 North America Rabies Immunoglobulins Market Size by Country
        6.3.1 North America Rabies Immunoglobulins Sales by Country (2017-2028)
        6.3.2 North America Rabies Immunoglobulins Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Rabies Immunoglobulins Market Size by Type
        7.1.1 Europe Rabies Immunoglobulins Sales by Type (2017-2028)
        7.1.2 Europe Rabies Immunoglobulins Revenue by Type (2017-2028)
    7.2 Europe Rabies Immunoglobulins Market Size by Application
        7.2.1 Europe Rabies Immunoglobulins Sales by Application (2017-2028)
        7.2.2 Europe Rabies Immunoglobulins Revenue by Application (2017-2028)
    7.3 Europe Rabies Immunoglobulins Market Size by Country
        7.3.1 Europe Rabies Immunoglobulins Sales by Country (2017-2028)
        7.3.2 Europe Rabies Immunoglobulins Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Rabies Immunoglobulins Market Size by Type
        8.1.1 Asia Pacific Rabies Immunoglobulins Sales by Type (2017-2028)
        8.1.2 Asia Pacific Rabies Immunoglobulins Revenue by Type (2017-2028)
    8.2 Asia Pacific Rabies Immunoglobulins Market Size by Application
        8.2.1 Asia Pacific Rabies Immunoglobulins Sales by Application (2017-2028)
        8.2.2 Asia Pacific Rabies Immunoglobulins Revenue by Application (2017-2028)
    8.3 Asia Pacific Rabies Immunoglobulins Market Size by Region
        8.3.1 Asia Pacific Rabies Immunoglobulins Sales by Region (2017-2028)
        8.3.2 Asia Pacific Rabies Immunoglobulins Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Rabies Immunoglobulins Market Size by Type
        9.1.1 Latin America Rabies Immunoglobulins Sales by Type (2017-2028)
        9.1.2 Latin America Rabies Immunoglobulins Revenue by Type (2017-2028)
    9.2 Latin America Rabies Immunoglobulins Market Size by Application
        9.2.1 Latin America Rabies Immunoglobulins Sales by Application (2017-2028)
        9.2.2 Latin America Rabies Immunoglobulins Revenue by Application (2017-2028)
    9.3 Latin America Rabies Immunoglobulins Market Size by Country
        9.3.1 Latin America Rabies Immunoglobulins Sales by Country (2017-2028)
        9.3.2 Latin America Rabies Immunoglobulins Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Rabies Immunoglobulins Market Size by Type
        10.1.1 Middle East and Africa Rabies Immunoglobulins Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Rabies Immunoglobulins Revenue by Type (2017-2028)
    10.2 Middle East and Africa Rabies Immunoglobulins Market Size by Application
        10.2.1 Middle East and Africa Rabies Immunoglobulins Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Rabies Immunoglobulins Revenue by Application (2017-2028)
    10.3 Middle East and Africa Rabies Immunoglobulins Market Size by Country
        10.3.1 Middle East and Africa Rabies Immunoglobulins Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Rabies Immunoglobulins Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 CSL Behring
        11.1.1 CSL Behring Corporation Information
        11.1.2 CSL Behring Overview
        11.1.3 CSL Behring Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 CSL Behring Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 CSL Behring Recent Developments
    11.2 Grifols
        11.2.1 Grifols Corporation Information
        11.2.2 Grifols Overview
        11.2.3 Grifols Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Grifols Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Grifols Recent Developments
    11.3 Sanofi
        11.3.1 Sanofi Corporation Information
        11.3.2 Sanofi Overview
        11.3.3 Sanofi Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sanofi Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sanofi Recent Developments
    11.4 Kamada
        11.4.1 Kamada Corporation Information
        11.4.2 Kamada Overview
        11.4.3 Kamada Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Kamada Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Kamada Recent Developments
    11.5 Sichuan Yuanda Shuyang
        11.5.1 Sichuan Yuanda Shuyang Corporation Information
        11.5.2 Sichuan Yuanda Shuyang Overview
        11.5.3 Sichuan Yuanda Shuyang Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sichuan Yuanda Shuyang Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sichuan Yuanda Shuyang Recent Developments
    11.6 Shuanglin Bio
        11.6.1 Shuanglin Bio Corporation Information
        11.6.2 Shuanglin Bio Overview
        11.6.3 Shuanglin Bio Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Shuanglin Bio Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Shuanglin Bio Recent Developments
    11.7 Weiguang Bio
        11.7.1 Weiguang Bio Corporation Information
        11.7.2 Weiguang Bio Overview
        11.7.3 Weiguang Bio Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Weiguang Bio Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Weiguang Bio Recent Developments
    11.8 Shanghai RAAS
        11.8.1 Shanghai RAAS Corporation Information
        11.8.2 Shanghai RAAS Overview
        11.8.3 Shanghai RAAS Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Shanghai RAAS Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Shanghai RAAS Recent Developments
    11.9 Bharat Serum
        11.9.1 Bharat Serum Corporation Information
        11.9.2 Bharat Serum Overview
        11.9.3 Bharat Serum Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Bharat Serum Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Bharat Serum Recent Developments
    11.10 VINS BioProducts
        11.10.1 VINS BioProducts Corporation Information
        11.10.2 VINS BioProducts Overview
        11.10.3 VINS BioProducts Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 VINS BioProducts Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 VINS BioProducts Recent Developments
    11.11 Tiantan Biological
        11.11.1 Tiantan Biological Corporation Information
        11.11.2 Tiantan Biological Overview
        11.11.3 Tiantan Biological Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Tiantan Biological Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Tiantan Biological Recent Developments
    11.12 Hualan Bio
        11.12.1 Hualan Bio Corporation Information
        11.12.2 Hualan Bio Overview
        11.12.3 Hualan Bio Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Hualan Bio Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Hualan Bio Recent Developments
    11.13 China-Boya
        11.13.1 China-Boya Corporation Information
        11.13.2 China-Boya Overview
        11.13.3 China-Boya Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 China-Boya Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 China-Boya Recent Developments
    11.14 China Biologic Products
        11.14.1 China Biologic Products Corporation Information
        11.14.2 China Biologic Products Overview
        11.14.3 China Biologic Products Rabies Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 China Biologic Products Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 China Biologic Products Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Rabies Immunoglobulins Industry Chain Analysis
    12.2 Rabies Immunoglobulins Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Rabies Immunoglobulins Production Mode & Process
    12.4 Rabies Immunoglobulins Sales and Marketing
        12.4.1 Rabies Immunoglobulins Sales Channels
        12.4.2 Rabies Immunoglobulins Distributors
    12.5 Rabies Immunoglobulins Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Rabies Immunoglobulins Industry Trends
    13.2 Rabies Immunoglobulins Market Drivers
    13.3 Rabies Immunoglobulins Market Challenges
    13.4 Rabies Immunoglobulins Market Restraints
14 Key Findings in The Global Rabies Immunoglobulins Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Rabies Immunoglobulins Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of ERIG
    Table 3. Major Manufacturers of HRIG
    Table 4. Global Rabies Immunoglobulins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Rabies Immunoglobulins Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Rabies Immunoglobulins Sales by Region (2017-2022) & (M Units)
    Table 7. Global Rabies Immunoglobulins Sales Market Share by Region (2017-2022)
    Table 8. Global Rabies Immunoglobulins Sales by Region (2023-2028) & (M Units)
    Table 9. Global Rabies Immunoglobulins Sales Market Share by Region (2023-2028)
    Table 10. Global Rabies Immunoglobulins Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Rabies Immunoglobulins Revenue Market Share by Region (2017-2022)
    Table 12. Global Rabies Immunoglobulins Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Rabies Immunoglobulins Revenue Market Share by Region (2023-2028)
    Table 14. Global Rabies Immunoglobulins Sales by Manufacturers (2017-2022) & (M Units)
    Table 15. Global Rabies Immunoglobulins Sales Share by Manufacturers (2017-2022)
    Table 16. Global Rabies Immunoglobulins Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Rabies Immunoglobulins Revenue Share by Manufacturers (2017-2022)
    Table 18. Rabies Immunoglobulins Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Rabies Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Rabies Immunoglobulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immunoglobulins as of 2021)
    Table 21. Rabies Immunoglobulins Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Rabies Immunoglobulins Product Offered
    Table 23. Date of Manufacturers Enter into Rabies Immunoglobulins Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Rabies Immunoglobulins Sales by Type (2017-2022) & (M Units)
    Table 26. Global Rabies Immunoglobulins Sales by Type (2023-2028) & (M Units)
    Table 27. Global Rabies Immunoglobulins Sales Share by Type (2017-2022)
    Table 28. Global Rabies Immunoglobulins Sales Share by Type (2023-2028)
    Table 29. Global Rabies Immunoglobulins Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Rabies Immunoglobulins Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Rabies Immunoglobulins Revenue Share by Type (2017-2022)
    Table 32. Global Rabies Immunoglobulins Revenue Share by Type (2023-2028)
    Table 33. Rabies Immunoglobulins Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Rabies Immunoglobulins Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Rabies Immunoglobulins Sales by Application (2017-2022) & (M Units)
    Table 36. Global Rabies Immunoglobulins Sales by Application (2023-2028) & (M Units)
    Table 37. Global Rabies Immunoglobulins Sales Share by Application (2017-2022)
    Table 38. Global Rabies Immunoglobulins Sales Share by Application (2023-2028)
    Table 39. Global Rabies Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Rabies Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Rabies Immunoglobulins Revenue Share by Application (2017-2022)
    Table 42. Global Rabies Immunoglobulins Revenue Share by Application (2023-2028)
    Table 43. Rabies Immunoglobulins Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Rabies Immunoglobulins Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Rabies Immunoglobulins Sales by Type (2017-2022) & (M Units)
    Table 46. North America Rabies Immunoglobulins Sales by Type (2023-2028) & (M Units)
    Table 47. North America Rabies Immunoglobulins Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Rabies Immunoglobulins Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Rabies Immunoglobulins Sales by Application (2017-2022) & (M Units)
    Table 50. North America Rabies Immunoglobulins Sales by Application (2023-2028) & (M Units)
    Table 51. North America Rabies Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Rabies Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Rabies Immunoglobulins Sales by Country (2017-2022) & (M Units)
    Table 54. North America Rabies Immunoglobulins Sales by Country (2023-2028) & (M Units)
    Table 55. North America Rabies Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Rabies Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Rabies Immunoglobulins Sales by Type (2017-2022) & (M Units)
    Table 58. Europe Rabies Immunoglobulins Sales by Type (2023-2028) & (M Units)
    Table 59. Europe Rabies Immunoglobulins Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Rabies Immunoglobulins Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Rabies Immunoglobulins Sales by Application (2017-2022) & (M Units)
    Table 62. Europe Rabies Immunoglobulins Sales by Application (2023-2028) & (M Units)
    Table 63. Europe Rabies Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Rabies Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Rabies Immunoglobulins Sales by Country (2017-2022) & (M Units)
    Table 66. Europe Rabies Immunoglobulins Sales by Country (2023-2028) & (M Units)
    Table 67. Europe Rabies Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Rabies Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Rabies Immunoglobulins Sales by Type (2017-2022) & (M Units)
    Table 70. Asia Pacific Rabies Immunoglobulins Sales by Type (2023-2028) & (M Units)
    Table 71. Asia Pacific Rabies Immunoglobulins Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Rabies Immunoglobulins Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Rabies Immunoglobulins Sales by Application (2017-2022) & (M Units)
    Table 74. Asia Pacific Rabies Immunoglobulins Sales by Application (2023-2028) & (M Units)
    Table 75. Asia Pacific Rabies Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Rabies Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Rabies Immunoglobulins Sales by Region (2017-2022) & (M Units)
    Table 78. Asia Pacific Rabies Immunoglobulins Sales by Region (2023-2028) & (M Units)
    Table 79. Asia Pacific Rabies Immunoglobulins Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Rabies Immunoglobulins Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Rabies Immunoglobulins Sales by Type (2017-2022) & (M Units)
    Table 82. Latin America Rabies Immunoglobulins Sales by Type (2023-2028) & (M Units)
    Table 83. Latin America Rabies Immunoglobulins Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Rabies Immunoglobulins Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Rabies Immunoglobulins Sales by Application (2017-2022) & (M Units)
    Table 86. Latin America Rabies Immunoglobulins Sales by Application (2023-2028) & (M Units)
    Table 87. Latin America Rabies Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Rabies Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Rabies Immunoglobulins Sales by Country (2017-2022) & (M Units)
    Table 90. Latin America Rabies Immunoglobulins Sales by Country (2023-2028) & (M Units)
    Table 91. Latin America Rabies Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Rabies Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Rabies Immunoglobulins Sales by Type (2017-2022) & (M Units)
    Table 94. Middle East and Africa Rabies Immunoglobulins Sales by Type (2023-2028) & (M Units)
    Table 95. Middle East and Africa Rabies Immunoglobulins Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Rabies Immunoglobulins Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Rabies Immunoglobulins Sales by Application (2017-2022) & (M Units)
    Table 98. Middle East and Africa Rabies Immunoglobulins Sales by Application (2023-2028) & (M Units)
    Table 99. Middle East and Africa Rabies Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Rabies Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Rabies Immunoglobulins Sales by Country (2017-2022) & (M Units)
    Table 102. Middle East and Africa Rabies Immunoglobulins Sales by Country (2023-2028) & (M Units)
    Table 103. Middle East and Africa Rabies Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Rabies Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
    Table 105. CSL Behring Corporation Information
    Table 106. CSL Behring Description and Major Businesses
    Table 107. CSL Behring Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. CSL Behring Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. CSL Behring Recent Developments
    Table 110. Grifols Corporation Information
    Table 111. Grifols Description and Major Businesses
    Table 112. Grifols Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Grifols Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Grifols Recent Developments
    Table 115. Sanofi Corporation Information
    Table 116. Sanofi Description and Major Businesses
    Table 117. Sanofi Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Sanofi Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Sanofi Recent Developments
    Table 120. Kamada Corporation Information
    Table 121. Kamada Description and Major Businesses
    Table 122. Kamada Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Kamada Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Kamada Recent Developments
    Table 125. Sichuan Yuanda Shuyang Corporation Information
    Table 126. Sichuan Yuanda Shuyang Description and Major Businesses
    Table 127. Sichuan Yuanda Shuyang Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Sichuan Yuanda Shuyang Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Sichuan Yuanda Shuyang Recent Developments
    Table 130. Shuanglin Bio Corporation Information
    Table 131. Shuanglin Bio Description and Major Businesses
    Table 132. Shuanglin Bio Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Shuanglin Bio Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Shuanglin Bio Recent Developments
    Table 135. Weiguang Bio Corporation Information
    Table 136. Weiguang Bio Description and Major Businesses
    Table 137. Weiguang Bio Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Weiguang Bio Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Weiguang Bio Recent Developments
    Table 140. Shanghai RAAS Corporation Information
    Table 141. Shanghai RAAS Description and Major Businesses
    Table 142. Shanghai RAAS Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Shanghai RAAS Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Shanghai RAAS Recent Developments
    Table 145. Bharat Serum Corporation Information
    Table 146. Bharat Serum Description and Major Businesses
    Table 147. Bharat Serum Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Bharat Serum Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Bharat Serum Recent Developments
    Table 150. VINS BioProducts Corporation Information
    Table 151. VINS BioProducts Description and Major Businesses
    Table 152. VINS BioProducts Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. VINS BioProducts Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. VINS BioProducts Recent Developments
    Table 155. Tiantan Biological Corporation Information
    Table 156. Tiantan Biological Description and Major Businesses
    Table 157. Tiantan Biological Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. Tiantan Biological Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Tiantan Biological Recent Developments
    Table 160. Hualan Bio Corporation Information
    Table 161. Hualan Bio Description and Major Businesses
    Table 162. Hualan Bio Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. Hualan Bio Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Hualan Bio Recent Developments
    Table 165. China-Boya Corporation Information
    Table 166. China-Boya Description and Major Businesses
    Table 167. China-Boya Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 168. China-Boya Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. China-Boya Recent Developments
    Table 170. China Biologic Products Corporation Information
    Table 171. China Biologic Products Description and Major Businesses
    Table 172. China Biologic Products Rabies Immunoglobulins Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 173. China Biologic Products Rabies Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. China Biologic Products Recent Developments
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Rabies Immunoglobulins Distributors List
    Table 178. Rabies Immunoglobulins Customers List
    Table 179. Rabies Immunoglobulins Market Trends
    Table 180. Rabies Immunoglobulins Market Drivers
    Table 181. Rabies Immunoglobulins Market Challenges
    Table 182. Rabies Immunoglobulins Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rabies Immunoglobulins Product Picture
    Figure 3. Global Rabies Immunoglobulins Market Share by Type in 2021 & 2028
    Figure 3. ERIG Product Picture
    Figure 4. HRIG Product Picture
    Figure 5. Global Rabies Immunoglobulins Market Share by Application in 2021 & 2028
    Figure 6. Category II Exposure
    Figure 7. Category III Exposure
    Figure 8. Rabies Immunoglobulins Report Years Considered
    Figure 9. Global Rabies Immunoglobulins Sales 2017-2028 (M Units)
    Figure 10. Global Rabies Immunoglobulins Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Rabies Immunoglobulins Revenue 2017-2028 (US$ Million)
    Figure 12. Global Rabies Immunoglobulins Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Rabies Immunoglobulins Sales Market Share by Region (2017-2022)
    Figure 14. Global Rabies Immunoglobulins Sales Market Share by Region (2023-2028)
    Figure 15. North America Rabies Immunoglobulins Sales YoY (2017-2028) & (M Units)
    Figure 16. North America Rabies Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Rabies Immunoglobulins Sales YoY (2017-2028) & (M Units)
    Figure 18. Europe Rabies Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Rabies Immunoglobulins Sales YoY (2017-2028) & (M Units)
    Figure 20. Asia-Pacific Rabies Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Rabies Immunoglobulins Sales YoY (2017-2028) & (M Units)
    Figure 22. Latin America Rabies Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Rabies Immunoglobulins Sales YoY (2017-2028) & (M Units)
    Figure 24. Middle East & Africa Rabies Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Rabies Immunoglobulins Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Rabies Immunoglobulins in the World: Market Share by Rabies Immunoglobulins Revenue in 2021
    Figure 27. Global Rabies Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Rabies Immunoglobulins Sales Market Share by Type (2017-2028)
    Figure 29. Global Rabies Immunoglobulins Revenue Market Share by Type (2017-2028)
    Figure 30. Global Rabies Immunoglobulins Sales Market Share by Application (2017-2028)
    Figure 31. Global Rabies Immunoglobulins Revenue Market Share by Application (2017-2028)
    Figure 32. North America Rabies Immunoglobulins Sales Market Share by Type (2017-2028)
    Figure 33. North America Rabies Immunoglobulins Revenue Market Share by Type (2017-2028)
    Figure 34. North America Rabies Immunoglobulins Sales Market Share by Application (2017-2028)
    Figure 35. North America Rabies Immunoglobulins Revenue Market Share by Application (2017-2028)
    Figure 36. North America Rabies Immunoglobulins Sales Share by Country (2017-2028)
    Figure 37. North America Rabies Immunoglobulins Revenue Share by Country (2017-2028)
    Figure 38. United States Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Rabies Immunoglobulins Sales Market Share by Type (2017-2028)
    Figure 41. Europe Rabies Immunoglobulins Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Rabies Immunoglobulins Sales Market Share by Application (2017-2028)
    Figure 43. Europe Rabies Immunoglobulins Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Rabies Immunoglobulins Sales Share by Country (2017-2028)
    Figure 45. Europe Rabies Immunoglobulins Revenue Share by Country (2017-2028)
    Figure 46. Germany Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 47. France Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Rabies Immunoglobulins Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Rabies Immunoglobulins Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Rabies Immunoglobulins Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Rabies Immunoglobulins Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Rabies Immunoglobulins Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Rabies Immunoglobulins Revenue Share by Region (2017-2028)
    Figure 57. China Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 60. India Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 66. Latin America Rabies Immunoglobulins Sales Market Share by Type (2017-2028)
    Figure 67. Latin America Rabies Immunoglobulins Revenue Market Share by Type (2017-2028)
    Figure 68. Latin America Rabies Immunoglobulins Sales Market Share by Application (2017-2028)
    Figure 69. Latin America Rabies Immunoglobulins Revenue Market Share by Application (2017-2028)
    Figure 70. Latin America Rabies Immunoglobulins Sales Share by Country (2017-2028)
    Figure 71. Latin America Rabies Immunoglobulins Revenue Share by Country (2017-2028)
    Figure 72. Mexico Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 73. Brazil Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 74. Argentina Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 75. Middle East and Africa Rabies Immunoglobulins Sales Market Share by Type (2017-2028)
    Figure 76. Middle East and Africa Rabies Immunoglobulins Revenue Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Rabies Immunoglobulins Sales Market Share by Application (2017-2028)
    Figure 78. Middle East and Africa Rabies Immunoglobulins Revenue Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Rabies Immunoglobulins Sales Share by Country (2017-2028)
    Figure 80. Middle East and Africa Rabies Immunoglobulins Revenue Share by Country (2017-2028)
    Figure 81. Turkey Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 82. Saudi Arabia Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 83. UAE Rabies Immunoglobulins Revenue (2017-2028) & (US$ Million)
    Figure 84. Rabies Immunoglobulins Value Chain
    Figure 85. Rabies Immunoglobulins Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed